We Need To Worry About Our Cholesterol Levels.
Many folks in their 30s and 40s chow down on burgers, fried chicken and other fatty foods without fear, figuring they have years before they necessity to fret about their cholesterol levels. But further research reveals that long-term revealing to even slightly higher cholesterol levels can damage a person's future magnanimity health. People at age 55 who've lived with 11 to 20 years of height cholesterol showed double the risk of heart disease compared to people that age with only one to 10 years of violent cholesterol, and quadruple the risk of people who had low cholesterol levels, researchers narrative online Jan 26, 2015 in the journal Circulation vimax. "The duration of time a individual has high cholesterol increases a person's risk of heart disease above and beyond the risk posed by their bruited about cholesterol level," said study author Dr Ann Marie Navar-Boggan, a cardiology auxiliary at the Duke Clinical Research Institute in Durham, NC "Adults with the highest duration of experience to high cholesterol had a fourfold increased risk of heart disease, compared with adults who did not have altered consciousness cholesterol".
Navar-Boggan and her colleagues concluded that for every 10 years a person has borderline-elevated cholesterol between the ages of 35 and 55, their danger of heart disease increases by nearly 40 percent. "In our 30s and 40s, we are laying the groundwork for the future of our heart health boxrxlist.com. For this study, which was partly funded by the US Agency for Healthcare Research and Quality, researchers relied on information from the Framingham Heart Study, one of the largest non-stop research projects focused on heart health.
Since 1948, families in the hamlet of Framingham, Mass, have allowed researchers to track their health. The researchers took 1,478 adults from the inquiry who had not developed heart disease by age 55, and then calculated the period of time each person had experienced high cholesterol by that age. They defined high cholesterol very conservatively in this study, pegging it at about 130 mg/dL of "bad" LDL cholesterol, a neck and neck which the US National Institutes of Health considers the lowest end of "borderline high" cholesterol.
Saturday, 28 February 2015
Friday, 27 February 2015
The Chest Pain And The Heart Attack
The Chest Pain And The Heart Attack.
For patients seen in danger rooms solely for breast pain, noninvasive screening tests may not always predict following heart trouble, a new study suggests. Such tests include: electrocardiograms, which cadence the heart's electrical activity, echocardiograms, which measure how well blood is flowing in the heart using ultrasound, and CT scans of the heart. All three tests are recommended for caddy pain under current guidelines, the survey authors said hair loss ka ilaaj krne wale doctor ko. "It may be safe to defer early cardiac stress testing in patients with casket pain but no evidence of a heart attack," said lead researcher Dr Andrew Foy, an deputy professor of medicine and public health sciences at the Penn State Milton S Hershey Medical Center in Hershey, PA.
Foy doesn't deem these tests are overused, but may not be needed in all cases. "Furthermore, pioneer cardiac stress testing appears to issue in unnecessary, additional tests and invasive treatments". Around 6 million patients go to the crisis room with chest pain each year in the United States. "Therefore, these findings could impact the caution of a large number of patients proextender gittigidiyor. Foy said that for patients with chest pain not brought on by a kindness attack, it seems safe to defer early cardiac stress tests.
So "We would stand up for they follow up closely with their primary care provider or cardiologist for the best advice on what to do after chest pain. If the nuisance returns, then cardiac stress testing may certainly be reasonable, depending on the nature of the pain and their other endanger factors for heart disease. The report was published online Jan 26, 2015 in the fortnightly JAMA Internal Medicine. For the study, Foy and his colleagues used constitution insurance claims from a group of almost 700000 privately insured patients seen in emergency rooms for thorax pain in 2011.
For patients seen in danger rooms solely for breast pain, noninvasive screening tests may not always predict following heart trouble, a new study suggests. Such tests include: electrocardiograms, which cadence the heart's electrical activity, echocardiograms, which measure how well blood is flowing in the heart using ultrasound, and CT scans of the heart. All three tests are recommended for caddy pain under current guidelines, the survey authors said hair loss ka ilaaj krne wale doctor ko. "It may be safe to defer early cardiac stress testing in patients with casket pain but no evidence of a heart attack," said lead researcher Dr Andrew Foy, an deputy professor of medicine and public health sciences at the Penn State Milton S Hershey Medical Center in Hershey, PA.
Foy doesn't deem these tests are overused, but may not be needed in all cases. "Furthermore, pioneer cardiac stress testing appears to issue in unnecessary, additional tests and invasive treatments". Around 6 million patients go to the crisis room with chest pain each year in the United States. "Therefore, these findings could impact the caution of a large number of patients proextender gittigidiyor. Foy said that for patients with chest pain not brought on by a kindness attack, it seems safe to defer early cardiac stress tests.
So "We would stand up for they follow up closely with their primary care provider or cardiologist for the best advice on what to do after chest pain. If the nuisance returns, then cardiac stress testing may certainly be reasonable, depending on the nature of the pain and their other endanger factors for heart disease. The report was published online Jan 26, 2015 in the fortnightly JAMA Internal Medicine. For the study, Foy and his colleagues used constitution insurance claims from a group of almost 700000 privately insured patients seen in emergency rooms for thorax pain in 2011.
Thursday, 12 February 2015
Node Negative Breast Cancer Is Better Treated By Chemotherapy
Node Negative Breast Cancer Is Better Treated By Chemotherapy.
A chemotherapy regimen already proven peerless to other regimens for soul cancer that has spread to the lymph nodes may also carry out better for some women whose cancers haven't spread, a new study has found. When it came to these "node-negative" cancers, the narcotic combination of docetaxel, doxorubicin and cyclophosphamide (dubbed TAC) outperformed the trust of fluorouracil, doxorubicin, and cyclophosphamide (FAC), the Spanish study authors said virilityex.drug-purchase.info. The TAC regimen was better at keeping women breathing and disease-free after a median follow up of almost six and a half years, the haunt found.
So "For those women with higher-risk, node-negative breast cancer, in which chemotherapy is indicated, TAC is one of the most provocative options," said study co-author Dr Miguel Martin, a professor of medical oncology at the Hospital General Universitario Gregorio Maranon in Madrid. The ruminate on was funded by the pharmaceutical maker Sanofi-Aventis - which makes Taxotere, the brand name for docetaxel - and GEICAM, the Spanish Breast Cancer Research Group antehealth. The results are published in the Dec 2, 2010 edition of the New England Journal of Medicine.
To select which women with teat cancer would benefit from adjuvant chemotherapy (typically chemotherapy after surgery), doctors use into account a number of risk factors, such as the patient's age, tumor size and other characteristics. For the original study, the researchers assigned 1060 women with breast cancers that were axillary-node cancelling who had at least one high-risk factor for recurrence to one of the two treatment regimens every three weeks for six cycles after their surgery.
At the 77-month mark, almost 88 percent of the TAC women were lousy and disease-free, compared to shut to 82 percent of the women in the FAC group. Those in the TAC rank had a 32 percent reduction in the risk of recurrence, the study authors said. The reduced endanger held true even after taking into account a number of high-risk factors, such as age, the women's menopausal repute and tumor characteristics.
A chemotherapy regimen already proven peerless to other regimens for soul cancer that has spread to the lymph nodes may also carry out better for some women whose cancers haven't spread, a new study has found. When it came to these "node-negative" cancers, the narcotic combination of docetaxel, doxorubicin and cyclophosphamide (dubbed TAC) outperformed the trust of fluorouracil, doxorubicin, and cyclophosphamide (FAC), the Spanish study authors said virilityex.drug-purchase.info. The TAC regimen was better at keeping women breathing and disease-free after a median follow up of almost six and a half years, the haunt found.
So "For those women with higher-risk, node-negative breast cancer, in which chemotherapy is indicated, TAC is one of the most provocative options," said study co-author Dr Miguel Martin, a professor of medical oncology at the Hospital General Universitario Gregorio Maranon in Madrid. The ruminate on was funded by the pharmaceutical maker Sanofi-Aventis - which makes Taxotere, the brand name for docetaxel - and GEICAM, the Spanish Breast Cancer Research Group antehealth. The results are published in the Dec 2, 2010 edition of the New England Journal of Medicine.
To select which women with teat cancer would benefit from adjuvant chemotherapy (typically chemotherapy after surgery), doctors use into account a number of risk factors, such as the patient's age, tumor size and other characteristics. For the original study, the researchers assigned 1060 women with breast cancers that were axillary-node cancelling who had at least one high-risk factor for recurrence to one of the two treatment regimens every three weeks for six cycles after their surgery.
At the 77-month mark, almost 88 percent of the TAC women were lousy and disease-free, compared to shut to 82 percent of the women in the FAC group. Those in the TAC rank had a 32 percent reduction in the risk of recurrence, the study authors said. The reduced endanger held true even after taking into account a number of high-risk factors, such as age, the women's menopausal repute and tumor characteristics.
Monday, 2 February 2015
With The Proper Treatment Of Patients With Diabetes Their Life Expectancy Is Not Reduced
With The Proper Treatment Of Patients With Diabetes Their Life Expectancy Is Not Reduced.
Advances in diabetes trouble oneself have nearly eliminated the adjustment in memoir expectancy between people with type 1 diabetes and the general population, according to new research. Life expectancy at descent for someone diagnosed with type 1 diabetes between 1965 and 1980 was estimated to be 68,8 years compared to 72,4 years for the shared population vito mol. But, for someone diagnosed with breed 1 diabetes between 1950 and 1964 the estimated life expectancy at origin was just 53,4 years.
So "The outlook for someone with type 1 diabetes can be wonderful," said the study's elder author, Dr Trevor Orchard, professor of epidemiology, medicine and pediatrics at the University of Pittsburgh Graduate School of Public Health Medicine. Orchard said that more fresh improvements in diabetes dolour will make the outlook even brighter for people diagnosed more recently.
And "We'll woo further improvements in life expectancy compared to the general population," he said. Results of the new muse about are scheduled to be presented on Saturday at the American Diabetes Association's annual meeting in San Diego.
Type 1 diabetes is an autoimmune disease, which means the body's inoculated system mistakenly sees salutary cells as foreign invaders, such as a virus. In type 1 diabetes, the immune structure attacks cells in the pancreas that produce insulin, a hormone necessary for your body to use carbohydrates as fuel. Once these cells are destroyed, the body can no longer bring about insulin.
People with type 1 diabetes must replace the disoriented insulin through injections or an insulin pump or they would get very ill and could even die. But, estimating the right extent of insulin you might need isn't an easy task. Too little insulin, and the blood sugar levels go too high.
Over time, high-priced blood sugar levels can damage many parts of the body, including the kidneys and the eyes. But if you get too much insulin, blood sugar levels can omit recklessly low, possibly low enough to cause coma or death.
Advances in diabetes trouble oneself have nearly eliminated the adjustment in memoir expectancy between people with type 1 diabetes and the general population, according to new research. Life expectancy at descent for someone diagnosed with type 1 diabetes between 1965 and 1980 was estimated to be 68,8 years compared to 72,4 years for the shared population vito mol. But, for someone diagnosed with breed 1 diabetes between 1950 and 1964 the estimated life expectancy at origin was just 53,4 years.
So "The outlook for someone with type 1 diabetes can be wonderful," said the study's elder author, Dr Trevor Orchard, professor of epidemiology, medicine and pediatrics at the University of Pittsburgh Graduate School of Public Health Medicine. Orchard said that more fresh improvements in diabetes dolour will make the outlook even brighter for people diagnosed more recently.
And "We'll woo further improvements in life expectancy compared to the general population," he said. Results of the new muse about are scheduled to be presented on Saturday at the American Diabetes Association's annual meeting in San Diego.
Type 1 diabetes is an autoimmune disease, which means the body's inoculated system mistakenly sees salutary cells as foreign invaders, such as a virus. In type 1 diabetes, the immune structure attacks cells in the pancreas that produce insulin, a hormone necessary for your body to use carbohydrates as fuel. Once these cells are destroyed, the body can no longer bring about insulin.
People with type 1 diabetes must replace the disoriented insulin through injections or an insulin pump or they would get very ill and could even die. But, estimating the right extent of insulin you might need isn't an easy task. Too little insulin, and the blood sugar levels go too high.
Over time, high-priced blood sugar levels can damage many parts of the body, including the kidneys and the eyes. But if you get too much insulin, blood sugar levels can omit recklessly low, possibly low enough to cause coma or death.
Subscribe to:
Posts (Atom)